Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2023: Oligonucleotide & Peptide Therapeutics

Date published: April 27, 2023

Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce sponsorship of TIDES USA 2023: Oligonucleotide & Peptide Therapeutics. Visit us at booth 416 in San Diego, CA, USA and meet our CEO, Dr. Brady Clark, our VP of Chemistry, Dr. Fengyang Yan, our COO, Remmick So and our newly appointed Chief Scientific Officer, Dr. Corwin Nycholat.

For over 25 years, we have enabled application of complex carbohydrate systems, including GalNAc and glycopeptides, in drug discovery, drug delivery, drug targeting, glycoconjugate vaccine development, immunotherapy, therapeutic enhancement and diagnostic/bio-analytical assay development. 

About Sussex Research Laboratories Inc.: Sussex Research Laboratories Inc. is a global leader in Carbohydrate Synthesis. We excel at translating complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit glycobiology in applications that promote human health. Our product portfolio and contract research & development services enable our clients and partners to apply discoveries in glycomics for drug development & discovery, drug delivery & targeting, vaccine development and monoclonal antibody development. Experience glyco-enhancement of your small molecule, protein, oligonucleotide or other macromolecule through Sussex Research Laboratories Inc.. We are the GalNAc, Glycan, Ligand, Glycopeptide and Glycoconjugate Specialists. For more information visit